Skip to ContentSkip to Navigation
How to find us prof. dr. J.C. (Hanneke) Kluin-Nelemans


The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial

Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial

Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification

Importance of Adequate Diagnostic Workup for Correct Diagnosis of Advanced Systemic Mastocytosis

Interim thymus and activation regulated chemokine versus interim F-18-fluorodeoxyglucose positron-emission tomography in classical Hodgkin lymphoma response evaluation

Late relapses in diffuse large B-cell lymphoma: where to move next?

Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts

Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis

Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry

Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions

Read more


Mastocytosis screening: use methylimidazole acetic acid in older overweight people